Protection of Human Subjects
and Institutional Review Boards
Revision of a currently approved collection
No
Regular
11/27/2023
Requested
Previously Approved
36 Months From Approved
03/31/2026
347,930
346,828
1,627,905
1,626,803
0
0
The information collection supports
FDA rulemaking 0910-AH52
US Code:
21 USC 301 et. seq. Name of Law: Federal Food, Drug, and
Cosmetic Act
US Code:
42 USC 241; 289 Name of Law: Public Health and Welfare;
Institutional Review Boards
PL: Pub.L. 114 - 255 3024 Name of Law: 21st
Century Cures Act
We estimate the rulemaking will
result in an annual burden increase of 1,102 responses and 1,102
hours from recordkeeping and disclosure activity relating to the
revised regulations in 21 CFR parts 50 and 56.
$8,750,000
No
No
No
No
No
No
No
Domini Bean 301 796-5733
domini.bean@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.